IPETX | VIVIX | IPETX / VIVIX | |
Total Expense Ratio | 1.09 | 0.04 | 2,725% |
Annual Report Gross Expense Ratio | 1.27 | 0.04 | 3,175% |
Fund Existence | 12 years | 27 years | - |
Gain YTD | -9.008 | 10.748 | -84% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 518M | 208B | 0% |
Annual Yield % from dividends | 1.33 | 2.09 | 63% |
Returns for 1 year | -8.84 | 8.21 | -108% |
Returns for 3 years | 23.65 | 49.10 | 48% |
Returns for 5 years | -41.35 | 73.42 | -56% |
Returns for 10 years | -42.23 | 132.88 | -32% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
LGDX | 22.66 | -0.05 | -0.21% |
Intech S&P Large Cap Diversified Alpha ETF | |||
EELV | 26.51 | -0.10 | -0.36% |
Invesco S&P Emerging Markets Low Vol ETF | |||
MDYV | 83.40 | -0.92 | -1.09% |
SPDR® S&P 400 Mid Cap Value ETF | |||
BOUT | 38.97 | -0.43 | -1.10% |
Innovator IBD® Breakout Opps ETF | |||
XJR | 42.18 | -0.62 | -1.46% |
iShares ESG Select Scrn S&P Small-CapETF |